ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.710G>A (p.Arg237Gln) (rs397516263)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000035994 SCV000059646 uncertain significance not specified 2015-08-21 criteria provided, single submitter clinical testing proposed classification - variant undergoing re-assessment, contact laboratory
Invitae RCV000471357 SCV000546271 uncertain significance Hypertrophic cardiomyopathy 2016-05-20 criteria provided, single submitter clinical testing This sequence change replaces arginine with glutamine at codon 237 of the MYH7 protein (p.Arg237Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a MYH7-related disease. ClinVar contains an entry for this variant (Variation ID: 43099). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance.
GeneDx RCV000766650 SCV000618119 uncertain significance not provided 2017-08-01 criteria provided, single submitter clinical testing The R237Q variant of uncertain significance in the MYH7 gene has been reported in one patient referred for hypertrophic cardiomyopathy (HCM) genetic testing (Walsh et al., 2017); however, additional clinical details and segregation information were not provided. Additionally, while a different nucleotide substitution at the same residue (R237W) has been reported in association with dilated cardiomyopathy, the proband also harbored a second possibly damaging variant (Hershberger et al., 2008), and thus, the pathogenicity of this variant has not been definitively determined. Nevertheless, the R237Q variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R237Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Finally, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function.
Ambry Genetics RCV000617410 SCV000736602 uncertain significance Cardiovascular phenotype 2016-05-20 criteria provided, single submitter clinical testing Insufficient evidence
Stanford Center for Inherited Cardiovascular Disease, Stanford University RCV000766650 SCV000924873 uncertain significance not provided 2017-06-20 no assertion criteria provided provider interpretation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.